Camlin Fine Sciences Ltd — Regulatory Filings 2020

Apr 1, 2020

==> picture [100 x 31] intentionally omitted <==

1[st] April, 2020

To, To, BSE Limited , The Manager, 25, P. J. Towers, Listing Department, Dalal Street, National Stock Exchange of India Ltd ., Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex, Ref: Company Scrip Code: 532834 Bandra (East), Mumbai- 400051 Ref: Symbol : CAMLINFINE || Series: EQ

Sub: Intimation for closure of Trading Window

Dear Sir/Madam,

This is to inform you that pursuant to the Company's Code of Conduct to regulate, monitor and report insider trading read with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and BSE Circular Ref. No. LIST/COMP/0l /2019-20 dated April 02, 2019, the trading window of the Company for dealing in the equity shares shall remain closed from April 1, 2020 till the end of 48 hours after the declaration of financial results for the quarter and financial year ended March 31, 2020. Further, the date of the Board Meeting for approving the financial results for the financial year ended 31[st] March, 2020 will be intimated in due course separately.

Kindly take the above information on record and acknowledge receipt

For Camlin Fine Sciences Limited

==> picture [92 x 24] intentionally omitted <==

Ashish Dandekar Managing Director

==> picture [426 x 57] intentionally omitted <==